Cellebrite Di Ltd. (CLBT)
NASDAQ:CLBT
Want to see CLBT full AI Analyst Report?
CLBT Stock Chart & Stats
$13.18
-$0.01(-0.05%)
At close: 4:00 PM EST
$13.18
-$0.01(-0.05%)
Day’s Range― - ―
52-Week Range$11.02 - $19.98
Previous CloseN/A
Volume262.11K
Average Volume (3M)2.23M
Market Cap
$3.67B
Enterprise Value$3.56B
Total Cash (Recent Filing)$429.07M
Total Debt (Recent Filing)$22.80M
Price to Earnings (P/E)50.5
Beta0.78
Next Earnings
Aug 12, 2026EPS Estimate
0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.29
Shares Outstanding249,439,820
10 Day Avg. Volume2,555,121
30 Day Avg. Volume2,230,866
Financial Highlights & Ratios
PEG Ratio-0.47
Price to Book (P/B)9.41
Price to Sales (P/S)9.58
P/FCF Ratio29.25
Enterprise Value/Market Cap0.97
Enterprise Value/Revenue7.18
Enterprise Value/Gross Profit8.56
Enterprise Value/Ebitda30.25
Forecast
1Y Price Target
$19.75Price Target Upside49.85% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)0.37
Revenue Forecast (FY)$567.97M
Bulls Say, Bears Say
Bulls Say
AI-driven Workflow AutomationAnalyst notes embedded AI and curated security guardrails streamline discovery and reduce manual work while preserving trust and compliance for public sector investigative workflows.
Product Differentiation And Competitive MoatAnalyst's recommendation highlights a strong competitive moat from an end-to-end investigative solution that uniquely accesses the latest phone models and centralizes digital evidence to speed investigations.
Recurring Revenue And Federal Market ExpansionAnalyst points to accelerating recurring revenue driven by conversion of existing deployments and higher attachment of new products, and federal security authorization expands availability of key products to U.S. agencies.
Bears Say
Competitive Threat From Advanced Detection ToolsAnalyst warns that competing tools with superior vulnerability detection could make it harder to break into new operating system versions, increasing competitive pressure.
Federal Contract UncertaintyAnalyst highlights that a pause in a major U.S. federal contract creates revenue uncertainty until a successor contract is signed and executed.
Margin Dilution And Currency HeadwindsAnalyst flags margin guidance that assumes dilution from the Corellium acquisition and currency headwinds, creating downside risk to profit margins.
Cellebrite DI News
CLBT FAQ
What was Cellebrite Di Ltd.’s price range in the past 12 months?
Cellebrite Di Ltd. lowest stock price was $11.02 and its highest was $19.98 in the past 12 months.
What is Cellebrite Di Ltd.’s market cap?
Cellebrite Di Ltd.’s market cap is $3.67B.
When is Cellebrite Di Ltd.’s upcoming earnings report date?
Cellebrite Di Ltd.’s upcoming earnings report date is Aug 12, 2026 which is in 72 days.
How were Cellebrite Di Ltd.’s earnings last quarter?
Cellebrite Di Ltd. released its earnings results on May 14, 2026. The company reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.054 by -$0.014.
Is Cellebrite Di Ltd. overvalued?
According to Wall Street analysts Cellebrite Di Ltd.’s price is currently Undervalued.
Does Cellebrite Di Ltd. pay dividends?
Cellebrite Di Ltd. does not currently pay dividends.
What is Cellebrite Di Ltd.’s EPS estimate?
Cellebrite Di Ltd.’s EPS estimate is 0.06.
How many shares outstanding does Cellebrite Di Ltd. have?
Cellebrite Di Ltd. has 249,439,820 shares outstanding.
What happened to Cellebrite Di Ltd.’s price movement after its last earnings report?
Cellebrite Di Ltd. reported an EPS of $0.04 in its last earnings report, missing expectations of $0.054. Following the earnings report the stock price went up 8.43%.
Which hedge fund is a major shareholder of Cellebrite Di Ltd.?
Currently, no hedge funds are holding shares in CLBT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cellebrite DI Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$19.75 (49.85% Upside)
$19.75 (49.85% Upside)
Blogger Sentiment
Neutral
CLBT Sentiment 50%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 198.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $199.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.8%
Last 30 Days ▲ 2.4%
Last 30 Days ▲ 2.4%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-12.21%
12-Months-Change
Fundamentals
Return on Equity
15.53%
Trailing 12-Months
Asset Growth
34.15%
Trailing 12-Months
Company Description
Cellebrite Di Ltd.
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation. The company's Universal Forensic Extraction Device solution addresses problems in accessing digital information, including complicated device locks, encryption barriers, deleted and unknown content, and other obstacles that can prevent critical evidence from coming to light. It also offers Seeker solution that provides the ability to analyze video footage; OSINT Analyze, a real-time deep dive solution used to analyze open-source information, such as the surface web, deep web, and the dark web; and Crypto Tracer, which analyzes blockchain transactions together with related data from an extensive list of sources to identify and categorize wallets, and transactions. The company serves federal and state and local agencies, as well as enterprise companies and service providers. It has operations in the United States, Germany, Singapore, Australia, Brazil, United Kingdom, France, Canada, Japan, and India. The company was incorporated in 1999 and is based in Petah Tikva, Israel. Cellebrite Mobile Synchronization Ltd. operates as a subsidiary of Sun Corporation.
CLBT Company Deck
CLBT Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call featured multiple strong financial and strategic highlights: ARR growth of 21% to $493M, revenue +19% to $128.3M, adjusted EBITDA +29% and robust free cash flow. Management delivered major product milestones (Genesis AI, Guardian Investigate), FedRAMP High authorization, improving regional momentum (U.S. Fed pipeline +35%, EMEA growth at 25%), and optimistic Q2 guidance that implies meaningful sequential acceleration. Lowlights were primarily execution and timing risks (seasonal Q1 softness, deal push-outs, acquisition-related costs), a modest near-term net-new ARR cadence, FX headwinds (~2 points) and the need to convert strong early AI adoption into paying customers. Overall the positives—especially the combination of strong financials, rapid AI adoption, large estimated AI TAM and strategic certifications—outweigh the transitory negatives, though execution will be important to sustain the opportunity.View all CLBT earnings summariesCLBT Stock 12 Month Forecast
Average Price Target
$19.75
▲(49.85% Upside)
Technical Analysis
Ownership Overview
0.40% Insiders
8.34% Mutual Funds
34.88% Other Institutional Investors
54.56% Public Companies and
Individual Investors